BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4329940)

  • 21. [Action of tolbutamide on glucagon secretion. I. Study in anesthesitized dogs].
    Loubatiéres AL; Loubatiéres-Mariani MM; Ribes G; Alric R
    C R Seances Soc Biol Fil; 1972; 166(12):1757-60. PubMed ID: 4665276
    [No Abstract]   [Full Text] [Related]  

  • 22. Diazoxide effects on biphasic insulin release: "adrenergic" suppression and enhancement in the perifused rat pancreas.
    Burr IM; Marliss EB; Stauffacher W; Renold AE
    J Clin Invest; 1971 Jul; 50(7):1444-50. PubMed ID: 5090060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of epinephrine and serotonin inhibition of insulin release in the golden hamster in vitro.
    Feldman JM; Lebovitz HE
    Diabetes; 1970 Jul; 19(7):480-6. PubMed ID: 4393305
    [No Abstract]   [Full Text] [Related]  

  • 24. Depressed tolbutamide-induced insulin response in subjects treated with propranolol.
    Massara F; Strumia E; Camanni F; Molinatti GM
    Diabetologia; 1971 Aug; 7(4):287-9. PubMed ID: 5093710
    [No Abstract]   [Full Text] [Related]  

  • 25. Adrenergic modulation of basal insulin secretion in man.
    Robertson RP; Porte D
    Diabetes; 1973 Jan; 22(1):1-8. PubMed ID: 4683792
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on the mechanism of xylitol-induced insulin secretion in dogs. Effect of its infusion into the pancreatic artery, and the inhibition by epinephrine and diazoxide of xylitol-induced hyperinsulinaemia.
    Kuzuya T; Kanazawa Y
    Diabetologia; 1969 Aug; 5(4):248-57. PubMed ID: 4902720
    [No Abstract]   [Full Text] [Related]  

  • 27. Diazoxide and the secretion of insulin.
    Nutr Rev; 1972 Aug; 30(8):194-8. PubMed ID: 4340200
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro secretion of insulin after glucose, sulphonylureas, adrenergic and cholinergic substances studied by isolated perfused rat pancreas.
    Loubatières A; Loubatières-Mariani MM
    Endocrinol Exp; 1974 Jun; 8(2):75-87. PubMed ID: 4209693
    [No Abstract]   [Full Text] [Related]  

  • 29. The morphological substrate of the inhibition of insulin secretion by diazoxide.
    Creutzfeldt W; Creutzfeldt C; Frerichs H; Perings E; Sicklinger K
    Horm Metab Res; 1969 Mar; 1(2):53-64. PubMed ID: 4334867
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of cyclic AMP and epinephrine on insulin and growth hormone secretion in sheep.
    Hertelendy F
    Horm Metab Res; 1971 Mar; 3(2):90-3. PubMed ID: 4330868
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of ethanol and its metabolites on insulin secretion.
    Bivens CH; Feldman JM
    Q J Stud Alcohol; 1974 Jun; 35(2):635-48. PubMed ID: 4610627
    [No Abstract]   [Full Text] [Related]  

  • 32. The mode of action of adenosine 3':5'-cyclic monophosphate in mammalian islets of Langerhans. Effects of insulin secretagogues on islet-cell protein kinase activity.
    Montague W; Howell SL
    Biochem J; 1973 May; 134(1):321-7. PubMed ID: 4353086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the role of adenylcyclase in insulin secretion.
    Bressler R; Cordon MV; Brendel K
    Arch Intern Med; 1969 Mar; 123(3):248-51. PubMed ID: 4303991
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of 2-deoxy-D-glucose on insulin-secretory responses to intravenous glucose, glucagon, tolbutamide and arginine in man.
    Goldsmith SJ; Yalow RS; Berson SA
    Diabetes; 1970 Jun; 19(6):453-7. PubMed ID: 4393032
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of insulin secretion by aryl-substituted secondary aminoethanols.
    Bressler R; Vargas-Cordon M; Brendel K
    Diabetes; 1969 May; 18(5):262-7. PubMed ID: 4307639
    [No Abstract]   [Full Text] [Related]  

  • 36. [Modification of insulin-secretion, induced by glucose, of the isolation-perfused rat pancreas using tolbutamide, glucosamine, diazoxide, glucagon and endogenous insulin].
    Bierwolf B; Blech W
    Acta Biol Med Ger; 1976; 35(5):583-95. PubMed ID: 983609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucagon secretion from the isolated perfused rat pancreas: influenced by the glucose-, tolbutamide- and pancreozymin-mediated release of pancreatic insulin.
    Fussgänger RD; Goberna R; Laube H; Schröder KE; Straub K; Pfeiffer EF
    Isr J Med Sci; 1972 Jun; 8(6):768-9. PubMed ID: 4559419
    [No Abstract]   [Full Text] [Related]  

  • 38. [Variations as a function of animal species of insulin response to the activation of beta adrenergic receptors].
    Loubatières-Mariani MM; Chapal J; Ribes G; Loubatières A
    C R Seances Soc Biol Fil; 1974; 168(8-9):1033-8. PubMed ID: 4156658
    [No Abstract]   [Full Text] [Related]  

  • 39. Basal and stimulated insulin levels: comparison of insulinogenic effects of oral glucose and intravenous tolbutamide in nondiabetic and diabetic subjects.
    Bagdade JD; Bierman EL; Porte D
    Metabolism; 1971 Nov; 20(11):1000-7. PubMed ID: 5115750
    [No Abstract]   [Full Text] [Related]  

  • 40. Diazoxide and D600 inhibition of insulin release. Distinct mechanisms explain the specificity for different stimuli.
    Henquin JC; Charles S; Nenquin M; Mathot F; Tamagawa T
    Diabetes; 1982 Sep; 31(9):776-83. PubMed ID: 6131003
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.